Compare PEB & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEB | ATRC |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | 52 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | N/A | 2005 |
| Metric | PEB | ATRC |
|---|---|---|
| Price | $14.82 | $28.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | $13.30 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 2.3M | 769.9K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | $2.25 | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $8.80 | $25.52 |
| 52 Week High | $14.96 | $43.18 |
| Indicator | PEB | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 62.57 | 48.66 |
| Support Level | $13.77 | $26.47 |
| Resistance Level | $14.85 | $30.75 |
| Average True Range (ATR) | 0.38 | 1.36 |
| MACD | 0.01 | 0.19 |
| Stochastic Oscillator | 86.87 | 64.79 |
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.